Our new zonal protection system keeps items on display- exactly where shoppers want them-while reducing employee involvement and simplifying the entire process THOROFARE, N.J., Feb. 19, 2026 ...

In December 2024, Checkpoint announced that the U.S. Food and Drug Administration (“FDA”) approved UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell ...